Literature DB >> 35794773

Epilepsy, Immunity and Neuropsychiatric Disorders.

Francesco Fortunato1, Alessia Giugno1, Ilaria Sammarra1, Angelo Labate2, Antonio Gambardella1,3.   

Abstract

Several studies have focused on the emerging role of immunity and inflammation in a wide range of neurological disorders. Autoimmune diseases involving central nervous system share well defined clinical features including epileptic seizures and additional neuropsychiatric symptoms, like cognitive and psychiatric disturbances. The growing evidence about the role of immunity in the pathophysiologic mechanisms underlying these conditions lead to the concept of autoimmune epilepsy. This relatively-new term has been introduced to highlight the etiological and prognostic implications of immunity in epileptogenesis. In this review, we aim to discuss the role of autoimmunity in epileptogenesis and its clinical, neurophysiological, neuroimaging and therapeutic implications. Moreover, we wish to address the close relationship between immunity and additional symptoms, particularly cognitive and psychiatric features, which deeply impact clinical outcome in these patients. To assess these aspects, we have first analyzed Rasmussen's encephalitis. Subsequently, we have covered autoimmune encephalitis, particularly those associated with autoantibodies against surface neuronal antigens, as these autoantibodies express a direct immune-mediated mechanism, different from those against intracellular antigens. Then, we have discussed about the connection between systemic immune disorders and neurological manifestations. This review aims to highlight the need to expand knowledge about the role of inflammation and autoimmunity in the pathophysiology of neurological disorders and the importance to early recognize these clinical entities. Indeed, early identification may result in faster recovery and a better prognosis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Epilepsy/Seizures; autoimmune encephalitis; immunity; immunotherapy; neuro-inflammation; neuropsychiatric disorders

Year:  2022        PMID: 35794773     DOI: 10.2174/1570159X20666220706094651

Source DB:  PubMed          Journal:  Curr Neuropharmacol        ISSN: 1570-159X            Impact factor:   7.363


  1 in total

1.  Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham's Chorea: A Multicenter Prospective Study.

Authors:  Alessandro Orsini; Thomas Foiadelli; Attilio Sica; Andrea Santangelo; Niccolò Carli; Alice Bonuccelli; Rita Consolini; Sofia D'Elios; Nicolò Loddo; Alberto Verrotti; Giuseppe Di Cara; Chiara Marra; Maria Califano; Anna Fetta; Marianna Fabi; Stefania Bergamoni; Aglaia Vignoli; Roberta Battini; Marta Mosca; Chiara Baldini; Nadia Assanta; Pietro Marchese; Gabriele Simonini; Edoardo Marrani; Francesca Felicia Operto; Grazia Maria Giovanna Pastorino; Salvatore Savasta; Giuseppe Santangelo; Virginia Pedrinelli; Gabriele Massimetti; Liliana Dell'Osso; Diego Peroni; Duccio Maria Cordelli; Martina Corsi; Claudia Carmassi
Journal:  Int J Environ Res Public Health       Date:  2022-08-25       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.